Common treatment for MIS-C patients likely works by depleting neutrophils

By | October 16, 2021
Intravenous immune globulin (IVIG) — a common treatment for multisystem inflammatory syndrome in children (MIS-C) — likely works by depleting immune cells called neutrophils, according to a recent study funded by the National Institutes of Health.